SpectaCell
SpectaCell develops a cell analysis platform combining imaging technology and AI analytics to assess cell therapy performance and accelerate the development and manufacturing of immunotherapies.
SpectaCell has raised €6.0M across 1 funding round from 5 investors, most recently a Seed round in Oct 2026. Based in Ghent, Belgium; active in Software. Data as of 28 Oct 2026.
Ghent, Belgiumwww.spectacell.com ↗
Total raised
€6.0M
€6,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDSpectaCell — funding by year — interactive chart.
Data table
| SpectaCell — funding by year | |
|---|---|
| 2026 | €6.0M |
Signals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-09 | Seed | €6.0M | imec.xpand,InnovationQuarter,PMV’s Flanders Future Tech Fund,Qbic,VIB | View deal → |